TNFB polymorphism may be associated with schizophrenia in the Korean population

Schizophrenia Research

Volumn 61, Issue 1, 2003, Pages 39-45

  Jun, Tae Youn ^a   Pae, Chi Un ^a   Chae, Jeong Ho ^a   Bahk, Won Myong ^a   Kim, Kwang Soo ^a   Han, Hoon ^b   Serretti, Alessandro ^c  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Association study; Schizophrenia; TNFB polymorphism

Indexed keywords

LYMPHOTOXIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SCHIZOPHRENIA;

EID: 0037400953     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00303-1     Document Type: Article

References (71)

1. Abraham L.J., French M.A., Dawkins R.L. Polymorphic MHC ancestral haplotypes affect the activity of tumor necrosis factor-alpha. Clin. Exp. Immunol. 92:1993;14-18.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. 1994;American Psychiatric Press, Washington, DC.
3. Benkmann H.G., Cho Y.H., Singh S., Wimmer U., Lee C.C., Kim I.K., Paik Y.K., Goedde H.W. Red cell enzyme and serum protein polymorphisms in South Korea. Hum. Hered. 39:1989;263-270.
4. Bettinotti M.P., Hartung K., Deicher H., Messer G., Keller E., Weiss E.H., Albert E.D. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics. 37:1993;449-454.
5. Boin F., Zanardini R., Pioli R., Altamura C.A., Maes M., Gennarelli M. Association between G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol. Psychiatry. 6:2001;79-82.
6. Brzustowicz L.M., Honer W.G., Chow E.W., Hogan J., Hodgkinson K., Bassett A.S. Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. Am. J. Hum. Genet. 61:1997;1388-1396.
7. Campbell R.D., Trowsdale J. Map of the human MHC. Immunol. Today. 14:1993;349-352.
8. Cohen J. Statistical power analysis for the behavioral sciences. 1988;Lawrence Erlbaum Associates, Hillsdale, NJ.
9. DeLisi L.E., Weinberger D.R., Potkin S., Neckers L.M., Shiling D.J., Wyatt R.J. Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients. Br. J. Psychiatry. 139:1981;513-518.
10. DeLisi L.E., Goodman S., Neckers L.M., Wyatt R.J. An analysis of lymphocyte subpopulations in schizophrenic patients. Biol. Psychiatry. 17:1982;1003-1009.
11. DeLisi L.E., Ortaldo J.R., Maluish A.E., Wyatt R.J. Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients. J. Neural Transm. 58:1983;99-106.
12. DeLisi L.E., Boccio A.M., Riordan H., Hoff A.L., Dorfman A., McClelland J., Kushner M., Van Eyl O., Oden N. Familial thyroid disease and delayed language development in first admission patients with schizophrenia. Psychiatry Res. 38:1991;39-50.
13. DeLisi L.E., Craddock N.J., Detera-Wadleigh S., Foroud T., Gejman P., Kennedy J.L., Lendon C., Macciardi F., McKeon P., Mynett-Johnson L., Nurnberger J.I. Jr., Paterson A., Schwab S., Van Broeckhoven C., Wildenauer D., Crow T.J. Update on chromosomal locations for psychiatric disorders: report of the interim meeting of chromosome workshop chairpersons from the VIIth World Congress of Psychiatric Genetics, Monterey, California, October 14-18, 1999. Am. J. Med. Genet. 96:2000;434-449.
14. DeLisi L.E., Smith A.B., Razi K., Stewart J., Wang Z., Sandhu H.K., Philibert R.A. Investigation of a candidate gene for schizophrenia on Xq13 previously associated with mental retardation and hypothyroidism. Am. J. Med. Genet. 96:2000;398-403.
15. Frommberger U.H., Bauer J., Haselbauer P., Fraulin A., Riemann D., Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatry Clin. Neurosci. 247:1997;228-233.
16. Ganguli R., Rabin B.S. Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects. Arch. Gen. Psychiatry. 46:1989;292.
17. Ganguli R., Rabin B.S., Kelly R.H., Lyte M., Ragu U. Clinical and laboratory evidence of autoimmunity in acute schizophrenia. Ann. N. Y. Acad. Sci. 496:1987;676-685.
18. Ganguli R., Rabin B.S., Belle S.H. Decreased interleukin-2 production in schizophrenic patients. Biol. Psychiatry. 26:1989;427-430.
19. Ganguli R., Brar J.S., Chengappa K.R., DeLeo M., Yang Z.W., Shurin G., Rabin B.S. Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms. Arch. Gen. Psychiatry. 52:1995;668-672.
20. Garner C., Kelly M., Cardon L., Joslyn G., Carey A., LeDuc C., Lichter J., Harris T., Loftus J., Shields G., Comazzi M., Vita A., Smith A.M., Dann J., Crow T.J., DeLisi L.E. Linkage analyses of schizophrenia to chromosome 6p24-p22: an attempt to replicate. Am. J. Med. Genet. 67:1996;595-610.
21. Garrard P., Hodges J.R., De Vries P.J., Hunt N., Crawford A., Hodges J.R., Balan K. Hashimoto's encephalopathy presenting as "myxodematous madness" J. Neurol., Neurosurg. Psychiatry. 68:2000;102-103.
22. Gilmore J.H., Jarskog L.F. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr. Res. 24:1997;365-367.
23. Goldbach J.M., Roth J., Storr B., Zeisberger E. Changes of abdominal temperature and circulating levels of cortisol and interleukin-6 in response to intra-arterial infusions of tumor necrosis factor-alpha or tumor necrosis factor-beta in guinea pigs. Eur. J. Pharmacol. 334:1997;249-254.
24. Katila H., Hanninen K., Hurme M. Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol. Psychiatry. 4:1999;179-181.
25. Kendler K.S., MacLean C.J., O'Neill F.A., Burke J., Murphy B., Duke F., Shinkwin R., Easter S.M., Webb B.T., Zhang J., Walsh D., Straub R.E. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am. J. Psychiatry. 153:1996;1534-1540.
26. Keso T., Perola M., Laippala P., Ilveskoski E., Kunnas T.A., Mikkelsson J., Penttila A., Hurme M., Karhunen P.J. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis. 154:2001;691-697.
27. Kim T.G., Kim H.Y., Lee S.H., Cho C.S., Park S.H., Choi H.B., Han H., Kim D.J. Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. Hum. Immunol. 46:1996;10-17.
28. Kirch D.G., Kaufmann C.A., Papadopoulos N.M., Martin B., Weinberger D.R. Abnormal cerebrospinal fluid protein indices in schizophrenia. Biol. Psychiatry. 20:1985;1039-1046.
29. Koch W., Kastrati A., Bottiger C., Mehilli J., von Beckerath N., Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 159:2001;137-144.
30. Kowalski J., Blada P., Kucia K., Madej A., Herman Z.S. Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophr Res. 50:2001;169-175.
31. Kronfol Z., Remick D.G. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry. 157:2000;683-694.
32. Lander E., Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:1995;241-247.
33. Libert C., Wielockx B., Grijalba B., Van Molle W., Kremmer E., Colten H.R., Fiers W., Brouckaert P. The role of complement activation in tumour necrosis factor-induced lethal hepatitis. Cytokine. 11:1999;617-625.
34. Lin A., Kenis G., Bignotti S., Tura G.J., De Jong R., Bosmans E., Pioli R., Altamura C., Scharpe S., Maes M. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr. Res. 32:1998;9-15.
35. Lindholm E., Ekholm B., Balciuniene J., Johansson G., Castensson A., Koisti M., Nylander P.O., Pettersson U., Adolfsson R., Jazin E. Linkage analysis of a large Swedish kindred provides further support for a susceptibility locus for schizophrenia on chromosome 6p23. Am. J. Med. Genet. 88:1999;369-377.
36. Maes M., Bosmans E., Calabrese J., Smith R., Meltzer H.Y. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 29:1995;141-152.
37. Maziade M., Roy M.A., Rouillard E., Bissonnette L., Fournier J.P., Roy A., Garneau Y., Montgrain N., Potvin A., Cliché D., Dion C., Wallot H., Fournier A., Nicole L., Lavallee J.C., Merette C. A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes. A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes. Mol. Psychiatry. 6:2001;684-693.
38. McGuffin P., Farmer A.E., Rajah S.M. Histocompatibility antigens and schizophrenia. Br. J. Psychiatry. 132:1978;149-151.
39. McGuffin P., Farmer A.E., Yonace A.H. HLA antigens and subtypes of schizophrenia. Psychiatry Res. 5:1981;115-122.
40. McQuaid S., Campbell R., Isserte S., Cosby S.L. Leukaemia inhibitory factor mRNA is expressed in the brains of patients with subacute sclerosing panencephalitis. J. Neuroimmunol. 77:1997;57-62.
41. Messer G., Spengler U., Jung M.C., Honold G., Blomer K., Pape G.R., Riethmuller G., Weiss E.H. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J. Exp. Med. 173:1991;209-219.
42. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated acid. Nucleic Acids Res. 16:1988;1215.
43. Molvig J., Pociot F., Baek L., Worsaae H., Dall Wogensen L., Christensen P., Staub-Nielsen L., Mandrup-Poulsen T., Manogue K., Nerup J. Monocyte function in IDDM patients and healthy individuals. Scand. J. Immunol. 32:1990;297-311.
44. Monteleone P., Fabrazzo M., Tortorella A., Maj M. Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment. Psychiatry Res. 71:1997;11-17.
45. Naudin J., Mege J.L., Azorin J.M., Dassa D. Elevated circulating levels of IL-6 in schizophrenia. Schizophr. Res. 20:1996;269-273.
46. Naudin J., Capo C., Giusano B., Mege J.L., Azorin J.M. A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia? Schizophr. Res. 26:1997;227-233.
47. Nimgaonkar V.L., Yang Z.W., Zhang X.R., Brar J.S., Chakravarti A., Ganguli R. Association study of schizophrenia and the IL-2 receptor beta chain gene. Am. J. Med. Genet. 60:1995;448-451.
48. Pulver A.E., Mulle J., Nestadt G., Swartz K.L., Blouin J.L., Dombroski B., Liang K.Y., Housman D.E., Kazazian H.H., Antonarakis S.E., Lasseter V.K., Wolyniec P.S., Thornquist M.H., McGrath J.A. Genetic heterogeneity in schizophrenia: stratification of genome scan data using co-segregating related phenotypes. Mol. Psychiatry. 5:2000;650-653.
49. Rapaport M.H., Torrey E.F., McAllister C.G., Nelson D.L., Pickar D., Paul S.M. Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur. Arch. Psychiatry Clin. Neurosci. 243:1993;7-10.
50. Rosler M., Bellaire W., Gressnich N., Giannitsis D., Jarovici A. HLA antigens in schizophrenia, major depressive disorder, and schizoaffective disorder. Med. Microbiol. Immunol. 172:1983;57-65.
51. Sasaki T., Matsushita M., Nanko S., Fukuda R., Kennedy J.L., Tokunaga K. Schizophrenia and the HLA-DRB1 gene in the Japanese population. Am. J. Psychiatry. 156:1999;771-773.
52. Schultz S.K., Andreasen N.C. Schizophrenia. Lancet. 353:1999;1425-1430.
53. Schwab S.G., Albus M., Hallmayer J., Honig S., Borrmann M., Lichtermann D., Ebstein R.P., Ackenheil M., Lerer B., Risch N., Maier W., Wildenauer D.B. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat. Genet. 11:1995;325-327.
54. Schwab S.G., Hallmayer J., Albus M., Lerer B., Eckstein G.N., Borrmann M., Segman R.H., Hanses C., Freymann J., Yakir A., Trixler M., Falkai P., Rietschel M., Maier W., Wildenauer D.B. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol. Psychiatry. 5:2000;638-649.
55. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
56. Spies T., Morton C.C., Nedospasov S.A., Fiers W., Pious D., Strominger J.L. Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc. Natl. Acad. Sci. U. S. A. 83:1986;8699-8702.
57. Straub R.E., MacLean C.J., O'Neill F.A., Burke J., Murphy B., Duke F., Shinkwin R., Webb B.T., Zhang J., Walsh D., Kendler J. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat. Genet. 11:1995;287-293.
58. Stüber F., Petersen M., Bokelmann F., Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit. Care Med. 24:1996;381-384.
59. Takara M., Komiya I., Kinjo Y., Tomoyose T., Yamashiro S., Akamine H., Masuda M., Takasu N. Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. Diabetes Care. 23:2000;975-978.
60. Tatsumi M., Sasaki T., Sakai T., Kamijima K., Fukuda R., Kunugi H., Hattori M., Nanko S. Genes for interleukin-2 receptor beta chain, interleukin-1 beta, and schizophrenia: no evidence for the association or linkage. Am. J. Med. Genet. 74:1997;338-341.
61. Theodoropoulou S., Spanakos G., Baxevanis C.N., Economou M., Gritzapis A.D., Papamichail M.P., Stefanis C.N. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Schizophr. Res. 47:2001;13-25.
62. Tomita Y., Hashimoto S., Yamagami K., Sawada S., Horie T. Restriction fragment length polymorphism (RFLP) analysis in the TNF genes of patients with systemic lupus erythematosus (SLE). Clin. Exp. Rheumatol. 11:1993;533-536.
63. van Kammen D.P., McAllister-Sistilli C.G., Kelley M.E., Gurklis J.A., Yao J.K. Elevated interleukin-6 in schizophrenia. Psychiatry Res. 87:1999;129-136.
64. Villemain F., Chatenoud L., Galinowski A., Homo-Delarche F., Ginestet D., Loo H., Zarifian E., Bach J.F. Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am. J. Psychiatry. 146:1989;609-616.
65. Wang S., Sun C.E., Walczak C.A., Ziegle J.S., Kipps B.R., Goldin L.R., Diehl S.R. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat. Genet. 10:1995;41-46.
66. Warzocha K., Ribeiro P., Bienvenu J., Roy P., Charlot C., Rigal D., Coiffier B., Salles G. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood. 91:1998;3574-3581.
67. Wright P., Gill M., Murray R.M. Schizophrenia: genetics and the maternal immune response to viral infection. Am. J. Med. Genet. 48:1993;40-46.
68. Wright P., Donaldson P.T., Underhill J.A., Choudhuri K., Doherty D.G., Murray R.M. Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. Am. J. Psychiatry. 153:1996;1530-1533.
69. Wright P., Nimgaonkar V.L., Donaldson P.T., Murray R.M. Schizophrenia and HLA: a review. Schizophr. Res. 47:2001;1-12.
70. Yamaguchi E., Itoh A., Hizawa N., Kawakami Y. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest. 119:2001;753-761.
71. Yamazaki K., Tabeta K., Nakajima T., Ohsawa Y., Ueki K., Itoh H., Yoshie H. Interleukin-10 gene promoter polymorphism in Japanese patients with adult and early-onset periodontitis. J. Clin. Periodontol. 28:2001;828-832.